- Home
- SIDU vs MYNZ Comparison
SIDU vs MYNZ Comparison
Compare SIDU & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIDU
- MYNZ
- Stock Information
- Founded
- SIDU 2012
- MYNZ 2021
- Country
- SIDU United States
- MYNZ Germany
- Employees
- SIDU N/A
- MYNZ N/A
- Industry
- SIDU Telecommunications Equipment
- MYNZ Biotechnology: Pharmaceutical Preparations
- Sector
- SIDU Telecommunications
- MYNZ Health Care
- Exchange
- SIDU Nasdaq
- MYNZ Nasdaq
- Market Cap
- SIDU 30.0M
- MYNZ 5.5M
- IPO Year
- SIDU 2021
- MYNZ 2021
- Fundamental
- Price
- SIDU $1.73
- MYNZ $1.40
- Analyst Decision
- SIDU
- MYNZ Buy
- Analyst Count
- SIDU 0
- MYNZ 2
- Target Price
- SIDU N/A
- MYNZ $14.00
- AVG Volume (30 Days)
- SIDU 702.0K
- MYNZ 120.1K
- Earning Date
- SIDU 08-18-2025
- MYNZ 07-07-2025
- Dividend Yield
- SIDU N/A
- MYNZ N/A
- EPS Growth
- SIDU N/A
- MYNZ N/A
- EPS
- SIDU N/A
- MYNZ N/A
- Revenue
- SIDU $3,860,985.00
- MYNZ $893,991.00
- Revenue This Year
- SIDU $144.49
- MYNZ $26.06
- Revenue Next Year
- SIDU N/A
- MYNZ $4.97
- P/E Ratio
- SIDU N/A
- MYNZ N/A
- Revenue Growth
- SIDU N/A
- MYNZ N/A
- 52 Week Low
- SIDU $1.14
- MYNZ $1.34
- 52 Week High
- SIDU $7.65
- MYNZ $22.40
- Technical
- Relative Strength Index (RSI)
- SIDU 58.29
- MYNZ 23.25
- Support Level
- SIDU $1.49
- MYNZ $1.34
- Resistance Level
- SIDU $1.82
- MYNZ $1.48
- Average True Range (ATR)
- SIDU 0.13
- MYNZ 0.13
- MACD
- SIDU 0.02
- MYNZ -0.01
- Stochastic Oscillator
- SIDU 72.73
- MYNZ 3.72
About SIDU Sidus Space Inc.
Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.